About us

Experts in life science and deep tech

Discover more

Our mission

We empower researchers, physicians and patients with ultra-sensitive whole-genome cancer detection.

Our SaaS solution utilizes a cloud-based platform to perform cancer tumor burden monitoring on a global scale, leveraging the thousands of already installed genome sequencers around the world. Using cutting-edge scientific breakthroughs, growing genomic and clinical databases, and sophisticated signal processing and AI, C2i enables high precision personalized medicine, reduced cancer treatment costs, and accelerated drug development.

Our Story

C2i Genomics was formally founded in 2019 and is based on technology developed at Cornell and the New York Genome Center. We are backed by top tier VCs.

Our Company is headquartered in the US with a CLIA lab in Cambridge, MA, and an R&D center in Israel. We have brought together outstanding professionals with multidisciplinary expertise in oncology, signal processing, bioinformatics and machine learning.

Locations

Our Offices

01.

New York

Our C2i Genomics headquarters is located in the thriving life science industry of NYC, in the modern and collaborative workspace at NYU BioLabs.

02.

Haifa

Our advanced R&D Center is located in Israel’s high-tech city of Haifa among top technology and life science companies.

03.

Cambridge

Our state-of-the-art CLIA certified lab is located in Cambridge, MA, surrounded by innovation and other leading research facilities.

Leadership

Meet our team

Our team brings together decades of experience across pharmaceutical and diagnostic research and commercialization, military intelligence and healthcare technology to revolutionize cancer monitoring.

Asaf Zviran, Ph.D CEO & CSO, Co-Founder

Ezra Sofer, MBA GM & CFO, Co-Founder

Boris Oklander, Ph.D CTO, Co-Founder

Mark Oldroyd, J.D CBO

Ravi Kandasamy, Ph.D VP R&D

David Sidransky, MD Director of Head and Neck Cancer Research, Johns Hopkins

Matija Snuderl, MD Director of Molecular Pathology, NYU Langone Health

Dan Landau, MD & PHD Scientific Co-founder Assistant Professor of Medicine, Weill Cornell Medicine Core Faculty Member, New York Genome Center

Seth Lerner, MD Professor and Director of Urologic Oncology, Baylor College of Medicine

Aparna Parikh, MD & MPH Assistant Professor and Gastrointestinal Oncologist, Massachusetts General Hospital

Yair Lotan, MD Professor and Chief of Urologic Oncology, UT Southwestern Medical Center

Levy Gerzberg, PhD Co-Founder, President, and CEO of Zoran Corp.

Asaf Zviran CEO & CSO, Co-Founder

Eli Casdin Casdin Capital

Shaun Rodriguez Casdin Capital

Ezra Sofer GM & CFO, Co-Founder

Alex Parker Independent Director

Anna Turetsky MFCR (Board Observer)

James Currier NFX (Board Observer)

Omri Amirav-Drory Tech.Bio (Board Observer)

Our Partnerships

Selected Investors

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus vestibulum aliquet est sit amet scelerisque. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae.

Careers

Join our team

Join us in empowering researchers, physicians and patients with ultra-sensitive cancer detection.

View positions